Aspira Women's Health (NASDAQ: AWHL) director granted 213,518-share stock option

Rhea-AI Filing Summary

Aspira Women's Health Inc. director Jeffrey Cohen reported a new stock option grant. On 12/02/2025, he received an option to buy 213,518 shares of Aspira Women's Health common stock at an exercise price of $0.35 per share. The option is exercisable starting on the grant date and expires on 12/02/2035. After this grant, Cohen beneficially owns 213,518 derivative securities directly in the form of this stock option, giving him potential future ownership if he chooses to exercise.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

cohen Jeffrey k

(Last) (First) (Middle)

C/O ASPIRA WOMEN'S HEALTH INC

12117 BEE CAVES RD, BLDG 3-100

(Street)

AUSTIN, TX 78738

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Aspira Women's Health Inc. [ AWHL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$0.35	12/02/2025		A		213,518		12/02/2025	12/02/2035	Common Stock	213,518	$0	213,518	D

Explanation of Responses:

	/s/ Jeffrey Cohen	12/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Aspira Women's Health (AWHL) report for Jeffrey Cohen?

Jeffrey Cohen, a directorstock option on 12/02/2025 covering 213,518 shares of common stock.

What is the exercise price of Jeffrey Cohen's new Aspira Women's Health (AWHL) stock option?

The stock option granted to Jeffrey Cohen has an exercise price of $0.35 per share for Aspira Women's Health common stock.

How many Aspira Women's Health (AWHL) shares underlie Jeffrey Cohen's reported stock option?

The reported stock option gives Jeffrey Cohen the right to purchase 213,518 shares of Aspira Women's Health common stock.

When does Jeffrey Cohen's Aspira Women's Health (AWHL) stock option expire?

The stock option granted on 12/02/2025 to Jeffrey Cohen expires on 12/02/2035, providing a 10-year exercise window.

How is Jeffrey Cohen's ownership reported in this Aspira Women's Health (AWHL) Form 4?

Following the reported transaction, Jeffrey Cohen beneficially owns 213,518 derivative securities in the form of a stock option, held with direct ownership.

What role does Jeffrey Cohen have at Aspira Women's Health (AWHL)?

Jeffrey Cohen is reported as a director of Aspira Women's Health Inc. and filed this Form 4 as a single reporting person.